Tag Archives: NASDAQ:TXMD

TherapeuticsMD (TXMD) Gets a Buy Rating from H.C. Wainwright

In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on TherapeuticsMD (TXMD – Research Report), with a price target of $7.00. The company’s shares closed last Monday at $2.85. According to TipRanks.com, Tsao is a

Noble Financial Sticks to Its Buy Rating for TherapeuticsMD (TXMD)

Noble Financial analyst Ahu Demir maintained a Buy rating on TherapeuticsMD (TXMD – Research Report) yesterday. The company’s shares closed last Monday at $3.78. According to TipRanks.com, Demir is a 3-star analyst with an average return of 5.8% and a

TherapeuticsMD (TXMD) Receives a Buy from Noble Financial

In a report issued on August 9, Ahu Demir from Noble Financial maintained a Buy rating on TherapeuticsMD (TXMD – Research Report), with a price target of $13. The company’s shares closed on Friday at $3.10. According to TipRanks.com, Demir

A Director at TherapeuticsMD (NASDAQ: TXMD) is Buying Shares

Today, a Director at TherapeuticsMD (TXMD – Research Report), Cooper Collins, bought shares of TXMD for $99.6K. This recent transaction increases Cooper Collins’ holding in the company by 83.33% to a total of $218.5K. In addition to Cooper Collins, one